Alliance QUANTUM trial to study bispecific immunotherapy for rare leukemia
Business Announcement
Updates every hour. Last Updated: 25-Oct-2026 05:16 ET (25-Oct-2026 09:16 GMT/UTC)
The Alliance for Clinical Trials in Oncology today announced the activation of The QUANTUM Trial (Alliance A062401), a clinical study designed to test a novel, immune-targeting approach for patients newly diagnosed with primary plasma cell leukemia (PCL).
Two new studies explain why certain nitrogenases are the most efficient at converting nitrogen gas into ammonia. The findings could help guide the engineering of enzymes or catalysts that can convert nitrogen gas to ammonia.
A previously unknown microprotein hidden within the human mitochondrial genome may help explain certain forms of Type 2 diabetes and could point toward a new, precision-medicine approach to treating it, according to a new USC study.